NRX Pharmaceuticals, Inc. (NRXP) Operating cash flow 2018–2025
NRX Pharmaceuticals, Inc. (NRXP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.1MFY2025 · since FY2018: -$473,187 → -$14.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.1M | -32.7% |
| FY2024 | -$10.6M | +50.9% |
| FY2023 | -$21.7M | +45.5% |
| FY2022 | -$39.8M | -5.4% |
| FY2021 | -$37.7M | -1564.6% |
| FY2020 | -$2.3M | -185.7% |
| FY2019 | -$792,731 | -67.5% |
| FY2018 | -$473,187 | — |
Source: SEC XBRL filings · For reference only · Not investment advice